MedicarePartD.guide

A non-government resource built from CMS public data

Hepatitis C drugs on AARP Medicare Rx Preferred from UHC (S5921-411)

Epclusa, Mavyret, Harvoni and their generics, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Oregon + 1 more
Premium
$110.00/month
Deductible
$130.00, doesn't apply to tier 1 and 2
Change plan

3 of 6 Hepatitis C drugs are covered on this plan. All 3 require prior authorization.

3 aren't on the formulary, including Epclusa and Harvoni.

  • sofosbuvir-velpatasvir
    generic Epclusa
    Covered · prior auth
    $2,648.73
    Tier 5
  • Mavyret
    glecaprevir and pibrentasvir
    Covered · prior auth
    from $4,393.26
    Tier 5
  • Vosevi
    sofosbuvir
    Covered · prior auth
    $8,450.10
    Tier 5
Not on the formulary
Epclusa, Harvoni, ledipasvir-sofosbuvir

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $130.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list